The clinical trial for the COVID-19 vaccine being developed by AstraZeneca and Britain’s University of Oxford has resumed in the
US traffic deaths fell 2% in 2019; 3rd straight yearly drop
Traffic deaths in the U.S. fell for the third consecutive year in 2019, the government’s road safety agency reported. The
Moderna’s COVID-19 vaccine won’t be ready by US election: report
US biotech firm Moderna won’t seek an emergency use authorization for its coronavirus vaccine before November 25, its CEO told
COVID-19 cases rising among US children as schools reopen
After preying heavily on the elderly in the spring, the coronavirus is increasingly infecting American children and teens in a
US hospital admissions for non-COVID-19 have only partially rebounded from initial decline
While declines in U.S. hospital admissions during the onset of COVID-19 has been well-documented, little is known about how admissions
US will pay J&J $1billion for 100 million coronavirus vaccine doses
Trump administration will pay Johnson & Johnson $1billion in exchange for 100 million coronavirus vaccine doses The US government is
Canada, US extend border restrictions to July 21.
Canada and the US have agreed to extend their agreement to keep their border closed to non-essential travel to July
As US, Europe reopen more, big nations see rising virus toll
American car makers are getting back to work and Europe is continuing to reopen. But while new coronavirus cases have
What history has taught us about epidemics
In the 1830s, a deadly cholera outbreak reached the city of Paris, France, where it killed approximately 20,000 people in
Why are so many of us feeling angry in lockdown?
Lockdown isn’t all baking, lunchtime sex and Zoom parties. For many people, it’s a scary experience that sees emotions go